Medication info

MultiHance Injection (Gadobenate Dimeglumine)

Prescription medicationApproval withdrawn
Ingredient · strength
Detapenta›Strength being verifiedGadolinium Oxide›Strength being verifiedMeglumine›Strength being verified
Manufacturer / importer
Bracco Imaging Korea
Appearance
This medication is a colorless and transparent injection solution contained in a colorless and transparent vial.
Packaging
5, 10, 15, 20 milliliters / vial
Approval status
Approval withdrawn

MFDS item code 200108879 · Approved 2001.07.18

This product's status changed to Approval withdrawn on 2023.03.28. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Enhancement of magnetic resonance imaging contrast for diagnosis of liver lesions
Who uses it
Adults
Adult dosage
This medicine is administered by intravenous bolus injection or slow intravenous infusion (10 mL/min) in the following cases. 1. Liver imaging: 0.1 mL/kg (0.05 mmol/kg) The liver shows an immediate contrast effect during bolus injection (dynamic MRI). For delayed MRI of the liver, diagnostic images may be obtained between 40-120 minutes, according to the diagnostic requirements.

Ingredients

Importer
Bracco Imaging Korea

Efficacy & effects

Enhancement of magnetic resonance imaging contrast for diagnosis of liver lesions

View approved original text

This medication helps enhance the visibility of the liver during magnetic resonance imaging (MRI) examinations. It is especially used for diagnosing liver lesions in patients with known or suspected primary liver cancer (hepatocellular carcinoma) or metastatic disease.

Dosage and Administration

Adult dosage

This medicine is administered by intravenous bolus injection or slow intravenous infusion (10 mL/min) in the following cases. 1. Liver imaging: 0.1 mL/kg (0.05 mmol/kg) The liver shows an immediate contrast effect during bolus injection (dynamic MRI). For delayed MRI of the liver, diagnostic images may be obtained between 40-120 minutes, according to the diagnostic requirements.

Precautions

This medication may cause serious side effects in patients with severely impaired kidney function or hepatic encephalopathy; therefore, it should be used with caution. In particular, the use of contrast agents should be limited in patients with decreased renal function, and renal function tests must be performed as necessary. The administered dose must not exceed the approved dosage, and when re-administering, the previously administered contrast agent must be sufficiently eliminated. In patients who have received gadolinium contrast agents multiple times, gadolinium may accumulate in the brain; therefore, the necessity of using the contrast agent should be considered carefully. This medication should not be administered to patients with allergies to specific components, pregnant women, or patients with severely impaired kidney function. It should be administered with caution in patients with cardiovascular disease, those with a history of allergies, and in children under 18 years of age. After using this medication, various adverse reactions such as skin rashes, itching, myalgia, nausea, and headaches may occur; if such symptoms arise, the patient should inform the healthcare provider immediately. Especially in patients with reduced kidney function, there is a risk of a serious side effect known as nephrogenic systemic fibrosis (NSF), so long-term monitoring is necessary. This medication must be administered in a professional medical institution where emergency relief is possible, and the patient must be observed by healthcare personnel for a certain period after administration. Pregnant or nursing women are advised to avoid the use of this medication; if nursing, they should stop breastfeeding for at least 24 hours after administration. Elderly patients are at a higher risk of reduced kidney function, so care must be taken regarding dosage adjustments and intervals between administrations. This medication must be injected precisely into the vein without dilution before injection and should not be mixed with other medications. Any remaining solution after use should be discarded and should not be frozen during storage. When administering this medication, the patient's medical history and renal function status must be thoroughly checked, and preparations should be made to respond quickly to any adverse reactions.

Side effects

  • Nephrogenic systemic fibrosis (NSF)
  • burning sensation
  • itching
  • redness or dark spots
  • skin swelling
  • hardening
  • stiffness
  • yellow spots on the sclera
  • joint stiffness
  • movement disorders of the arms
Show 154 more
  • hands
  • legs
  • and feet
  • deep pain in the hip bones or ribs
  • myasthenia
  • nasopharyngitis
  • headache
  • sensory disturbances
  • dizziness
  • fainting
  • abnormal olfaction
  • tremors
  • hypersensitivity
  • increased intracranial pressure
  • hemiplegia
  • conjunctivitis
  • tinnitus
  • palpitations
  • atrial fibrillation
  • first-degree AV block
  • ventricular extrasystoles
  • bradycardia
  • tachycardia
  • arrhythmia
  • myocardial ischemia
  • prolonged PR interval
  • vasodilation
  • hypertension
  • hypotension
  • rhinitis
  • idiopathic dyspnea
  • laryngospasm
  • wheezing
  • pulmonary congestion
  • pulmonary edema
  • nausea
  • dry mouth
  • dysgeusia
  • diarrhea
  • vomiting
  • indigestion
  • salivation
  • abdominal pain
  • constipation
  • fecal incontinence
  • necrotizing pancreatitis
  • pruritus
  • rash
  • facial edema
  • urticaria
  • sweating
  • lumbar pain
  • myalgia
  • urinary incontinence
  • urinary urgency
  • injection site reactions
  • heat sensation
  • asthenia
  • fever
  • chills
  • chest pain
  • pain
  • injection site pain
  • injection site leakage
  • injection site inflammation
  • abnormal clinical test results
  • ECG abnormalities
  • prolonged QT interval
  • hypopigmented anemia
  • leukocytosis
  • leukopenia
  • basophilia
  • hypoalbuminemia
  • hypocalcemia
  • hyperkalemia
  • hyperglycemia
  • hypoglycemia
  • proteinuria
  • diabetes
  • hematuria
  • hyperlipidemia
  • hyperbilirubinemia
  • increased serum iron
  • increased serum transaminases
  • increased alkaline phosphatase
  • increased lactate dehydrogenase
  • increased serum creatinine
  • left or right bundle branch block
  • increased heart rate
  • auditory disturbances
  • decreased vision
  • limb arterial embolism
  • bronchitis
  • tongue swelling
  • hematoma
  • chest pain
  • constrictive dermatitis
  • allergic dermatitis
  • fatigue
  • muscle cramps
  • myotonic contractions
  • limb pain
  • drowsiness
  • migraine
  • hematuria
  • decreased renal function
  • urethritis
  • dehydration
  • elevated liver enzymes
  • monocytosis
  • erythrocytosis
  • increased platelet count
  • increased γ-glutamyl transferase
  • increased neutrophils
  • decreased hematocrit
  • decreased hemoglobin
  • lymphocytosis
  • increased urine specific gravity
  • heart murmurs
  • lung rales
  • nausea
  • vomiting
  • anaphylactic shock
  • hypersensitivity reactions
  • pseudoanaphylaxis reactions
  • angioedema
  • laryngeal spasms
  • rash
  • localized pain
  • burning sensation
  • swelling
  • vesicle formation
  • cardiac arrest
  • hypotension
  • warmth sensation
  • itching
  • skin rash
  • cold sensation
  • feeling of pressure
  • dizziness
  • pain
  • abdominal pain
  • diarrhea
  • pseudoanaphylaxis symptoms
  • chest pain
  • urticaria
  • tremors
  • general anesthesia symptoms
  • cough
  • dyspnea
  • respiratory anxiety
  • laryngospasm
  • myalgia
  • urinary incontinence

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container that can prevent air and moisture. The appropriate storage temperature is in a cool place between 1 and 25 degrees Celsius.

Appearance and packaging

Appearance

This medication is a colorless and transparent injection solution contained in a colorless and transparent vial.

Package unit

5, 10, 15, 20 milliliters / vial

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.